GlassScriptPhysician profile
Grant Atkins
NPI 1942068838
$672.55
in general payments reported to CMS, 2019-2025
9 companies · $547 in 2025
The $547 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $126 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $205.33 | 2025 | Artegraft Vascular Graft |
| Solventum Corporation | $174.24 | 2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Stryker Corporation | $88.91 | 2025 | Artix Mt |
| Terumo Medical Corporation | $57.89 | 2024 | Azur Cx Detachable |
| Imperative Care, INC | $48.34 | 2025 | Symphony Catheter |
| Medtronic, INC. | $33.36 | 2024 | Endurant Iis |
| Molnlycke Health Care US, LLC | $29.86 | 2025 | Mepilex Border Post-Op |
| Convatec INC. | $21.53 | 2024 | |
| Bard Peripheral Vascular, INC. | $13.09 | 2024 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Atkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.